Company ProfilePremium

Hiscox Ltd

Company Profile Analysis

Ticker: HSX.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
Hiscox Ltd - Company showcase

Year Founded & Workforce

1901

3,000 Employees

Hiscox Ltd logo

Hiscox Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Hiscox Ltd Overview

Hiscox is a Bermuda-headquartered, London-listed pure-play specialty insurer. It runs a deliberately balanced portfolio that pairs low-volatility, compounding retail specialty insurance with cyclical, catastrophe-exposed big-ticket and reinsurance underwriting.

Hiscox Retail is the group's largest and fastest-compounding engine at $2.63bn ICWP in FY2025. It sells specialist commercial and personal lines to small businesses, professionals and high-net-worth individuals in the UK, Europe and the US. Distribution runs through brokers, partners and direct digital channels.

Hiscox London Market (Lloyd's Syndicate 33) and Hiscox Re (including the newly branded Hiscox Capital Partners ILS platform) provide high-margin specialty, property and reinsurance exposure. They are actively managed through the underwriting cycle.

The model delivered three consecutive years of record pre-tax profit to FY2025 ($732.7m). It also produced a decade-best undiscounted combined ratio of 87.8% and operating ROTE of 20.9%. Hiscox is now executing a $200m efficiency programme and a target of double-digit retail growth by 2028. It is also the subject of unconfirmed takeover speculation involving Intact Financial.


Company's own description

In its FY2025 and H1 2026 releases, Hiscox describes itself as a global specialty insurer headquartered in Bermuda and listed on the LSE. Its stated ambition is to remain among the world's most respected specialist insurers, with a portfolio diversified by product and geography.

Its core philosophy is balance. Catastrophe-exposed business is paired with less volatile local specialty business to create profitable growth opportunities throughout the insurance cycle. In its own framing:

  • The retail businesses in the USA, UK and Europe offer specialist commercial and personal lines.

  • Internationally traded, bigger-ticket business and reinsurance are written through Hiscox London Market and Hiscox Re.

Independent characterisation

Hiscox operates as a three-engine specialty (re)insurer with a capital-light fee overlay.

1. Hiscox Retail — the compounder.

  • Writes small-ticket, high-volume specialist lines: professional indemnity, small-business liability, cyber, high-net-worth home and contents, and fine art.

  • Sells through brokers, partners/affinity relationships and direct-to-consumer digital channels ("DPD": direct and partnerships distribution in the US).

  • Hiscox claims a 20-year unbroken record of compounding premium growth in Retail (H1 2026 release).

  • Growth is volume-led: policy count growth is outpacing rate, and retail rates rose only about 1% in H1 2026.

  • Strategic weight is shifting toward Retail. It is the main beneficiary of the $200m change programme and the double-digit growth ambition.

2. Hiscox London Market — the cycle manager.

  • Big-ticket specialty written through Lloyd's Syndicate 33.

  • Lines include major property, marine and energy, kidnap and ransom, war, terrorism and political violence, and product recall.

  • Rates are now falling (-5% in H1 2026) from a generational peak (+59% cumulative since 2018). Hiscox is shrinking selectively; for example, it non-renewed 23% of its power and renewables book.

3. Hiscox Re & Hiscox Capital Partners — risk-taker and asset gatherer.

  • Property catastrophe, specialty and pro-rata reinsurance written from Bermuda, London and Paris.

  • Paired with a third-party capital platform: ILS funds, cat bond funds and quota-share partners.

  • ILS assets under management rose from $1.5bn (1 Jan 2026) to $2.9bn (1 Jul 2026).

  • Fee income reached $53m in H1 2026. Hiscox Re is reducing net exposure while growing gross via partner capital, a structural shift toward fee-earning, capital-light reinsurance.

Revenue model

Revenue typeDescriptionApprox. share (FY2025)
Insurance revenue (earned premium, IFRS 17)Core underwriting revenue across all three segments$4,883.7m insurance revenue (five-year summary, FY2025)
Investment resultReturn on c.$9.3bn of financial assets and cash$442.7m (FY2025)
Third-party capital feesILS management and performance fees; quota-share overriding commissions$109.4m fee income in FY2025 (2024: $128.2m). $53m in H1 2026 alone.
Product / subscription / licensingNot applicable. Hiscox does not sell software or licences.—

Value-chain position

Hiscox is a risk carrier and underwriter. It is not a broker or distributor of third-party products, although it owns direct digital distribution in the US, UK and Europe. It sits between:

  • Distribution (brokers, MGAs, affinity partners, digital marketplaces)

  • Capital providers (shareholders, ILS investors, reinsurers)

It buys outward reinsurance and retrocession, and through Hiscox Re it also sells reinsurance to other carriers.

Customer types and end-markets

SegmentCustomer typesEnd-markets
Retail – UK, Europe, USAMicro-businesses, SMEs, professionals (consultants, IT contractors, architects, accountants; new 2026 appetite for forensic scientists, food technologists, podcasters, online tutors); high-net-worth households; art collectorsUK, Ireland, Germany, France, Netherlands, Belgium, Spain, Portugal and other European markets (ten European markets per FY2025 release); USA
London MarketCorporates, energy companies, shipowners, multinationals, specialty buyers via Lloyd's brokersGlobal
Hiscox ReInsurance companies (cedants), governments / emerging-market climate-resilience buyers (parametric), mortgage and surety marketsGlobal, with US property catastrophe as the largest peril region (inferred from LA wildfire exposure)
Hiscox Capital PartnersInstitutional ILS investors (pension funds, endowments, asset managers)Global investors

Strategy

Stated strategy (themes from FY2025 Report and May 2025 Capital Markets Day)

Change programme phasing (USD Mn)FY2025FY2026FY2028
Target P&L benefit2975200

Overarching aim: Deliver attractive and sustainable shareholder returns by exploiting the group's diversified business model, differentiated exposure to specialty markets and specialist technical capabilities.

Addressable market: Hiscox sizes its annualised target addressable market at $317bn.

Retail growth ambition: Accelerate Retail ICWP growth to double digits by 2028 by gaining share in sizeable serviceable addressable markets. The path is 6.3% (2025), then 8% guidance for 2026, upgraded to 9% in August 2026.

Change programme: An annualised $200m P&L benefit from 2028 against a 2024 baseline, with a $200m cost to achieve. Most of the benefit falls in Retail, across claims, attributable expenses and non-attributable expenses.

Actuals to date: $29m delivered in FY2025; $45m delivered in H1 2026 at a cost of $39m.

Big-ticket cycle management: London Market and Re are managed through the cycle, shrinking net exposure where rates are inadequate.

Capital efficiency: - Operate within a BSCR range of 190–200%.

  • Progressive dividend per share after a 20% step-up in the final FY2025 DPS (delivered: 35.9¢).

  • Recurring buybacks from surplus capital.

Technology and AI: Hiscox describes AI-enabled operational capabilities driving productivity gains and operating leverage. Examples:

  • AI-assisted lead underwriting in terrorism

  • AI submission triage in art and private client

  • Digital direct quote-and-bind in the US

Strategic initiatives (last 24 months)

InitiativeDateDetail
Capital Markets Day targetsMay 2025Double-digit Retail growth by 2028; $200m change programme; BSCR range; dividend step-up
Change programme execution2025–2028$29m (2025), $45m (H1 2026); tracking ahead of linear phasing
Product acceleration2,025More product launches in 2025 than in the previous five years combined (CEO, FY2025)
European cyber rolloutH1 2026Cyber product extended from France and Germany to all European markets
New UK/Retail appetiteH1 2026Forensic scientists, food technologists, podcasters, online tutors
Hiscox Capital Partners launch2,026Consolidates third-party capital and ILS under one brand. AUM up 93% year-to-date to $2.9bn.
Climate and resilience capability (Hiscox Re)2,025Parametric products for emerging markets
Distribution deals2023–2026Partnerships signed over three years now reaching scale
Revenue and marketing leadershipJul 2026New Group CMRO role to drive customer-led growth
DirectAsia exit2,025Completes withdrawal from Asian direct motor
Buyback programmes2025, 2026$175m (2025), $300m (2026)

Medium-term guidance (current)

MetricGuidance
Hiscox Retail ICWP growth (constant currency)9% for FY2026 (upgraded from 8% on 5 Aug 2026); double digits by 2028
Hiscox Retail undiscounted combined ratioWithin an 89–94% operating range, improving gradually within it
Change programme benefit$75m (2026); $200m annualised (2028 onward)
Group returnsThrough-the-cycle mid-teens ROTE
CapitalOperate within 190–200% BSCR
DividendProgressive DPS. Interim set at one-third of prior-year total.

The ROTE target was exceeded in FY2025 (20.9%) and in H1 2026 (20.2%).

Products & Services

Pricing is not publicly disclosed for any line. Hiscox prices per risk, and US and UK small-business products are quoted online.

Hiscox Retail — Hiscox UK (FY2025 ICWP $962.4m, +8.4% constant currency)

Product / brandDescriptionTarget customerNotes
Professional indemnityLiability cover for errors and omissionsConsultants, IT, marketing, design, finance professionalsHistoric UK franchise core; sold direct and via brokers
Small business / SME commercial combinedPublic liability, employers' liability, property, business interruptionMicro and small businessesGrowth driven by distribution deals, brand investment and sector specialisms (Q1 and H1 2026)
Cyber and data risksFirst- and third-party cyber, breach responseSMEsHiscox publishes an annual Cyber Readiness Report (brand asset)
Private client / high-net-worth homeBuildings, contents, valuables, artHigh-net-worth individualsUK Private Client grew double digits in 2025 (FY2025 call). NPS above 80 cited in H1 2026 call.
Fine art and specieArt collections, collectors, galleriesCollectors and institutionsMoved into Retail reporting from FY2025. AI tool cut review time of priority submissions from 2.5 days to 2.5 hours (2024).
New 2026 appetiteNiche professional classesForensic scientists, food technologists, podcasters, online tutorsAdded in H1 2026

Hiscox Retail — Hiscox Europe (FY2025 ICWP $710.9m, +6.1% constant currency)

ProductDescriptionMarketsNotes
Professional liability / D&OSpecialist liability for professionals and managementGermany, France (largest markets) plus othersGermany is the "flagship of Europe" (management bio of R. Dietrich)
CyberSME cyber productFirst launched in France and Germany; rolled out across all European markets in H1 2026—
Art and private clientsHigh-value home, artPan-European—
Direct-to-consumer and technology linesDigital direct and tech E&OGermany-led—

European operating markets in the FY2025 release total ten; country websites include Germany, France, Netherlands, Belgium, Spain, Portugal and Ireland.

Hiscox Retail — Hiscox USA (H1 2026 ICWP $535.9m, +8.1%)

Channel / productDescriptionNotes
Digital direct (DPD)Online quote-and-bind small-business insurance: general liability, professional liability, business owner's policiesUS DPD grew 7.0% in FY2025. Digital direct delivered record premium in H1 2026.
PartnershipsEmbedded and affinity distribution through partnersPart of DPD. Distribution deals take around 18 months to scale (H1 2026 call).
US brokerSpecialty small-commercial via retail and wholesale brokersReturned to growth: +0.7% FY2025, +1.5% Q1 2025
FloodPlusPrivate flood insurance, an alternative to the NFIPLaunched 2016
CyberSmall-business cyberPart of the US product set

Hiscox London Market (FY2025 ICWP $1,249m; Syndicate 33)

LineDescription2025–26 stance
Major property / US property D&FLarge commercial propertySelective; rates softening
Power and renewablesEnergy transition and power assets23% of book non-renewed in H1 2026 on rate inadequacy
Marine, energy and specialtyHull, cargo, energyGrew in Q1 2025
War, terrorism and political violenceIncluding AI-assisted terrorism lead underwriting (from 2024)Middle East loss of $40m in H1 2026 (with marine war and K&R)
Kidnap and ransomSpecial risks—
Product recall—Exposure being reduced (H1 2026 call)
Cyber / D&O / large bindersFinancial linesReduced in 2024 cycle management
Space—Ceased (2024)

Cumulative London Market rate change was +59% since 2018 at H1 2026, after -4% in 2025 and -5% in H1 2026.

Hiscox Re & Hiscox Capital Partners

OfferingDescriptionNotes
Property catastrophe reinsuranceExcess-of-loss cat cover for cedantsRates: -5% in 2025, -13% at 1 Jan 2026, -16% across H1 2026. Net cat exposure being reduced.
Specialty and pro-rataQuota share and specialty classesGrowth driver in 2025
Parametric climate resilienceParametric covers for emerging-market and climate-resilience buyersCapability developed in 2025
Mortgage and suretySpecialty reinsurance linesGrowth lines (FY2025)
Hiscox Capital Partners – ILS fundsManaged ILS strategies, bespoke mandates and managed accountsAUM $1.5bn (1 Jan 2026) → $2.4bn (1 Apr 2026) → $2.9bn (1 Jul 2026)
Cat bond fundsCatastrophe bond strategies$1.0bn of the $1.4bn gross H1 2026 inflows went into cat bond funds (Artemis)
Quota-share partnershipsThird-party capital sharing Hiscox Re's portfolioFY2025 fee income from ILS and QS partners: $109.4m

Financial Narrative

Note on standards. FY2021 is reported under IFRS 4/IAS 39 and is not directly comparable. FY2022 onward is IFRS 17 (restated).

Income statement

Sources: Hiscox five-year summary (website, unaudited); FY2025 preliminary results.

  • FY2021 figures are IFRS 4 and were corrected for transposition on the company site.

  • FY2023 PAT includes a $150m deferred tax credit related to the Bermuda ETA.

  • Gross profit and EBITDA are not reported by Hiscox and are not meaningful for an insurer.

Margins and growth (derived)

Sources: undiscounted combined ratios per Hiscox filings as reported by Insurance Business (Feb 2026). The FY2021 combined ratio is on the IFRS 4 basis.

Insurance revenue CAGR FY2022–FY2025 (derived): 4.5% per year.

Commentary.

Profitability inflection: FY2022 was the inflection year. PBT more than doubled from $275.6m to $625.9m in FY2023 as:

  • the hard market earned through London Market and Re;

  • higher bond yields lifted the investment result;

  • Retail margins began to expand after the 2019–2020 US casualty and COVID BI issues.

Steady compounding since: PBT grew +9.5% in FY2024 and +6.9% in FY2025.

Tax drag on net income: The rising effective tax rate depresses PAT. Bermuda introduced a 15% corporate income tax from 2025. Management cites a 2.5-percentage-point drag on FY2025 operating ROTE. This is why PAT fell in FY2025 despite record PBT, and why ROE declined from 19.8% to 17.1%.

Reserve releases: FY2025's underwriting result was materially supported by $292.7m of positive prior-year development, double the FY2024 level. Releases spanned all accident years 2021–2024. This is a quality-of-earnings point: releases of this size are unlikely to recur indefinitely as softening rates feed into new accident years.

Balance sheet

Sources and caveats:

  • Hiscox five-year summary (FY2021 insurance liabilities are on the IFRS 4 basis).

  • H1 2026 NAV per share: 1,234.9¢.

  • Total assets were not captured in this research.

  • See the debt investor page and the 2025 Report and Accounts.

NAV per share CAGR FY2021–FY2025 (derived): about 13.3% per year, before dividends.

Commentary.

Investment portfolio growth: The portfolio grew about 27% over four years to $9.3bn. Cash was redeployed into fair-value assets: cash fell from $1.44bn (2023) to $0.88bn (2025) while financial assets rose $1.86bn. This lifts recurring yield ("earn-through of higher coupons").

Goodwill and intangibles: The rise to $381.0m in FY2025 (+$72m) is consistent with capitalised technology investment under the change programme. Hiscox does not undertake large acquisitions.

Capital surplus: Equity growth has been tempered by heavy capital return. The BSCR still rose to 233% (FY2025 estimate) from 229%, well above the 190–200% operating range. That surplus funds the buybacks.

Cash flow and capital return

Notes on capital return:

  • Operating cash flow and capex were not captured from the cash flow statement; the primary PDF was not machine-accessible.

  • The FY2025 programme ($175m) was launched with the FY2024 results in February 2025.

  • The FY2026 programme ($300m) was announced on 25 Feb 2026. It was 32% complete at 30 June 2026, with completion expected before the FY2026 results.

  • Cumulative dividends and buybacks announced over three years exceed $1.1bn (FY2025 results).

Return and leverage ratios

Ratio notes:

  • The FY2025 BSCR is an estimate.

  • H1 2026 adjusted operating ROTE (annualised) was 20.2%, against 14.5% in H1 2025.

  • Current ratio, net debt/EBITDA, asset turnover and cash conversion cycle are not meaningful for an insurer.

  • ROA, ROIC, debt/equity and interest coverage cannot be computed without verified total assets, borrowings and finance costs.

Interim 2026 snapshot

Commentary.

Headline vs underlying: The reported PBT decline is driven by a net fair value loss on financial assets of $78.4m, against a $61.1m gain in H1 2025. Management expects these unrealised losses on fixed-income securities to unwind as the bonds mature.

Underwriting strength: The underlying picture is materially stronger: ISR +30%, adjusted operating PBT +26%, and a 220bp better combined ratio.

Change programme: The programme delivered a $45m P&L benefit in H1 against $39m cost to achieve. It is on track for $75m in FY2026 and $200m in 2028.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Insurance revenue (USD Mn)

—4,273.34,483.24,672.54,883.7

Insurance contract written premium (USD Mn)

———4,703.74,979.0

Net ICWP (USD Mn)

———3,622.43,865.8

Insurance service result (USD Mn)

———553.5613.9

Investment result (USD Mn)

———383.9442.7

Positive prior-year development (USD Mn)

———145.5292.7

Adjusted operating profit before tax (USD Mn)

———683.3743.8

Profit before tax (USD Mn)

190.8275.6625.9685.4732.7

Profit after tax (USD Mn)

189.5253.9712.0627.2604.1

Basic EPS (US cents)

55.373.8206.1183.2180.7

Diluted EPS (US cents)

54.772.7201.5178.1175.0

Adjusted operating EPS (US cents)

———184.4183.9

Dividend per share (US cents)

34.536.037.543.150.3

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Pre-tax margin on insurance revenue (%)

—6.414.014.715.0

Net margin on insurance revenue (%)

—5.915.913.412.4

Effective tax rate (%)

0.77.9-13.88.517.6

Insurance revenue growth (%)

——4.94.24.5

Undiscounted group combined ratio (%)

—90.689.889.287.8

Discounted group combined ratio (%)

93.288.785.584.783.7

Dividend payout ratio on basic EPS (%)

62.448.818.223.527.8

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Goodwill and intangible assets (USD Mn)

313.1320.4323.9308.8381.0

Financial assets at fair value (USD Mn)

6,041.35,812.16,574.47,077.68,432.0

Cash and cash equivalents (USD Mn)

1,300.71,350.91,437.01,227.0878.0

Total investments plus cash (USD Mn, derived)

7,342.07,163.08,011.48,304.69,310.0

Insurance liabilities net of reinsurance assets (USD Mn)

-4,690.4-4,177.1-4,505.7-4,419.5-5,052.7

Other net assets / (liabilities) (USD Mn)

-155.4-671.3-532.9-504.0-690.5

Net assets / shareholders' equity (USD Mn)

2,539.32,635.03,296.73,689.93,947.9

Tangible net assets (USD Mn, derived)

2,226.22,314.62,972.83,381.13,566.9

Net asset value per share (US cents)

739.8764.5951.51,086.41,220.0

Dividends & Capital Returns

MetricFY2025

Share buybacks announced (USD Mn)

175

Returns & Leverage Ratios (%)

RatioFY2021FY2022FY2023FY2024FY2025

Return on equity (%)

8.110.127.619.817.1

Operating return on tangible equity (%)

———24.120.9

BSCR (%)

———229233

Per-Share Data

MetricH1 2025H1 2026Change

ICWP

2,941.63,238.4+10.1%

Net ICWP

2,125.22,269.3+6.8%

Insurance service result

196.2255.4+30.2%

Investment result

234.9128.2-45.4%

Profit before tax

276.6240.5-13.1%

Adjusted operating PBT

262.0331.0+26.3%

EPS (¢)

67.282.3+22.5%

Adjusted operating EPS (¢)

63.9105.2+64.6%

Interim DPS (¢)

14.416.8+16.7%

NAV per share (¢)

1,133.31,234.9+9.0%

Revenue by Region

Retail region ICWP (USD Mn)FY2024FY2025

Hiscox UK (incl. Ireland)

864.0962.4

Hiscox Europe

656.5710.9

Hiscox USA (residual, derived)

920.5960.7

Retail Region Details

Retail regionFY2025 growth (constant currency)Main drivers

Hiscox UK

+8.4%

Strong double-digit new-business growth

Hiscox Europe

+6.1%

Germany and France

Hiscox USA

DPD +7.0%; broker +0.7%

DPD led by digital direct

Revenue by Region (Q1 2025–H1 2026)

Region ICWP (USD Mn)Q1 2025Q1 2026H1 2025H1 2026

Hiscox UK

——463.4530.2

Hiscox Europe

273.5328.2427.2494.6

Hiscox USA

253.2—496.0535.9

Retail total

736.1847.21,390.01,560.7

London Market

329.7342.8—733.2

Hiscox Re

492.2527.1887.3944.5

Geographic Revenue

RegionQ1 2026H1 2026

Hiscox UK

+8.9%+10.2%

Hiscox Europe

+6.8%+6.2%

Hiscox USA

+8.5%+8.1%

Retail total

+8.0%+8.2%

Share price (GBp)

Share price (GBp)FY2021FY2022FY2023FY2024FY2025

Annual high

1,004.01,106.51,193.01,281.01,454.0

Annual low

770.0827.2938.0998.01,022.0

Performance Details

PerformanceValueBasis

1-year

About +45–51%

Börse Stuttgart 1-year performance of +50.6% (2 Sep 2026); 52-week low about 1,288p versus 1,867p now

3-year

Approximately +75–90%

Illustrative, from the 2023 trading range (938–1,193p); not exact

5-year

Approximately +100–130%

Illustrative, from the 2021 trading range (770–1,004p); not exact

Peak

Record high in May 2026 on Intact reports

—

Valuation Multiples

MultipleHiscoxNotes

P/E (TTM)

About 13.2–13.3x

Aggregator data (Aug–Sep 2026). Börse Stuttgart shows 10.4x on a different EPS basis.

P/B

About 2.0x (illustrative)

H1 2026 NAV of 1,234.9¢ per share, converted at an assumed USD/GBP of 1.33, against a 1,867p share price.

EV/EBITDA, EV/Sales

Not meaningful for insurers

—

Dividend yield

About 2.05–2.08%

Aggregators (Sep–Oct 2026)

Peer reference

Zurich/Beazley takeover at 1,335p per share

Strategic multiple benchmark

Analyst Ratings & Targets

BrokerDateRatingTarget

Barclays

4 Sep 2026

Overweight

2,030p (from 1,820p)

Unnamed (investing.com feed)

4 Sep 2026

Buy

2,030p

Unnamed

7–10 Aug 2026

Buy

2,150p

Unnamed

6 Aug 2026

Hold

1,846p

Unnamed

5 Aug 2026

Buy

2,050p

RBC Capital Markets

26 Feb 2026

Raised target

Not captured

Jefferies

—

Double downgrade to Underperform

Not captured

Dividend (US cents)

Dividend (US cents)FY2021FY2022FY2023FY2024FY2025

Total DPS

34.536.037.543.150.3

Final DPS

———29.935.9

Credit Ratings

AgencyEntityRatingOutlook

AM Best

Hiscox Insurance Co (Bermuda), Hiscox Insurance Co Ltd (UK), Hiscox Insurance Co (Guernsey), Hiscox Insurance Co Inc (US)

FSR A (Excellent); ICR a+

Not captured

AM Best

Hiscox Ltd (holding company)

ICR bbb+

Not captured

AM Best

Lloyd's Syndicate 33

FSR A; ICR a+ (historical affirmation)

—

S&P

Hiscox operating entities

——

Moody's

Hiscox Ltd

——

Fitch

Hiscox Ltd

——

Analyst Conclusions

Management guidance (5 Aug 2026)

  • Outlook described as "positive".

  • FY2026 Retail ICWP growth of 9% constant currency, upgraded from 8%, with double digits by 2028.

  • Retail undiscounted COR improving gradually within 89–94%.

  • Change programme: $75m in 2026 and $200m in 2028.

  • Through-the-cycle ROTE in the mid-teens. Actual performance is running at about 20%.

  • Completion of the $300m buyback before FY2026 results.

  • Continued cycle management in big-ticket, with net cat exposure reducing at Hiscox Re.

Consensus expectations

Detailed consensus EPS and premium forecasts were not available from primary sources. The sell-side tone after the H1 results was predominantly Buy/Overweight, with targets clustered at 1,850–2,150p. One notable bear is Jefferies (Underperform).

Bull case

  1. Retail mix shift drives quality compounding. Retail growth is accelerating (6.3%, then 8.2% in H1, then 9% guidance) toward double digits. Combined with $200m of change benefits, mostly in Retail, this could take Retail PBT well above FY2025's $352m. Earnings would become less cyclical and could justify a re-rating.

  2. Capital-light fee engine. Hiscox Capital Partners AUM is $2.9bn, nearly doubled year-to-date. H1 fee income of $53m is already half of FY2025's $109m. The fee line can offset big-ticket softening.

  3. Strategic scarcity and M&A floor. Beazley's sale to Zurich and Intact's reported interest establish a strategic valuation framework. A 233% BSCR also supports ongoing buybacks of about 5% of the share count per year.

Bear case

  1. Big-ticket margins have peaked. London Market rates fell 5% and Re rates 16% in H1 2026. London Market's COR has already deteriorated to 93.8% (from 87.9%). Re's 60s combined ratios are unlikely to persist.

  2. Reserve releases and investment marks flatter results. FY2025 PYD of $292.7m (about 40% of PBT) cannot be repeated indefinitely. The H1 2026 fair-value loss of $78.4m shows how sensitive reported earnings are to rates. Bermuda CIT permanently lowers ROE.

  3. Speculative premium. The shares hit records on unconfirmed Intact reports. Without a bid, valuation at about 13x P/E and about 2x book may compress toward peers, especially if H2 2026 brings meaningful hurricane losses.

Key catalysts and monitorables (next 12 months)

CatalystTiming
Q3 2026 trading statement (Retail growth versus 9%; Re net exposure; H2 cat losses)Late Oct / early Nov 2026
Any Takeover Code announcement involving Intact or another bidderAny time
1 Jan 2027 reinsurance renewals (rate trajectory; ILS inflows)Jan 2027
FY2026 results: change benefit versus $75m; PYD level; FY2027 Retail guidance; new buyback sizeExpected 3 Mar 2027 (aggregator calendar)
Board refreshment (NEDs reaching nine years in Nov 2026)2026–27
Q1 2027 trading statementMay 2027
2027 AGM and 2026 Directors' Remuneration ReportSpring 2027

Concluding analyst verdict

Hiscox enters late 2026 in the strongest operational position of its modern history.

It has delivered three consecutive record pre-tax profits, culminating in $732.7m in FY2025, and a decade-best 87.8% undiscounted combined ratio. H1 2026 added double-digit premium growth and a 20.2% adjusted operating ROTE, with both a $60m Middle East loss and significant fair-value investment losses absorbed. The equity story has clearly pivoted. Hiscox is no longer primarily a Lloyd's and reinsurance cycle play. It is a retail specialty compounder with a cyclical, increasingly fee-based big-ticket overlay.

The key analytical tension is timing. Retail is accelerating just as big-ticket pricing softens: London Market rates fell 5% and Re rates 16% in H1 2026, and London Market's combined ratio has already moved into the 90s. Group earnings growth over 2027–2028 therefore depends on three things:

  • Retail delivering 9–10%+ growth at stable or improving margins;

  • the change programme hitting its $200m benefit;

  • Hiscox Capital Partners converting rapid AUM growth into durable fees.

The early evidence on all three is encouraging. The $45m H1 change benefit is ahead of linear phasing, Retail guidance has been upgraded, and ILS AUM has nearly doubled.

Offsetting this, reported earnings remain flattered by large reserve releases and are exposed to bond marks, catastrophe activity and a permanently higher Bermuda tax rate. The share price, near record levels at about 1,867p, already embeds some takeover optionality from the unconfirmed Intact reports.

Verdict: a high-quality, well-capitalised specialty franchise with credible self-help and capital-return support. Fundamentals justify a constructive stance. However, the risk-reward at current levels is more balanced than a year ago. The next 12 months hinge on hurricane-season outcomes, Q3 Retail momentum, the 1 January 2027 renewals and any formal M&A development. Investors should monitor PYD normalisation and London Market margins as the principal downside indicators.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleJoined / in rolePrior rolesEducation

Aki Hussain

Group CEO (Executive Director)

Joined 2016 as Group CFO; CEO since Jan 2022

Prudential plc (CFO Prudential UK & Europe); FD Consumer Bank, Lloyds Banking Group; FD Consumer, ntl (Virgin Media)

Chartered Accountant (trained at KPMG)

Paul Cooper

Group CFO (Executive Director)

May 2022

Interim Group CFO M&G plc; CFO Prudential Assurance Co.; Group CFO Canopius; Group CFO Arrow Global; FD Hiscox Insurance Co.; Partner EY; ABI board member

BA Economics (Manchester); Chartered Accountant (PwC)

Joanne Musselle

Group Chief Underwriting Officer

Joined 2002; Group CUO since end-2019

AXA, Aviva (UK and Asia); Hiscox UK claims, UK CUO, Retail CUO

—

Fabrice Brossart

Group Chief Risk Officer

Nov 2023

AIG (CRO International General Insurance); AXA Insurance UK (Chief Actuary)

Actuary

Shali Vasudeva

Group Chief Operations & Technology Officer

Jan 2025

COO AXA UK & Ireland (five years)

—

Aparna Sarin

Group Chief Marketing & Revenue Officer (new role)

Jul 2026

CMO Business Cards & Payments, Capital One; American Express

—

Nicola Grant

Chief People Officer

Sep 2022

17 years at ING Group

—

Shirley Girling

Group General Counsel

2026

WTW (GC Risk & Broking); AXA; Capita; private practice

Solicitor (England & Wales)

Marc Wetherhill

Company Secretary

2017

PartnerRe (Chief Legal Counsel); Appleby

Solicitor; Bermuda Bar (2001)

Mary Boyd

CEO, Hiscox USA

2024

CEO independent agency business, Plymouth Rock; SVP The Hartford; President Private Risk Services, Chubb

Began as an actuarial trainee

Robert Dietrich

CEO, Hiscox Europe

Mar 2021 (joined 1997)

MD Hiscox Germany (15 years)

—

Jon Dye

CEO, Hiscox UK

Sep 2022

CEO Allianz UK (eight years); Chair ABI 2019–21; Chubb, Commercial Union

Law (Cambridge); FCII

Kate Markham

CEO, Hiscox London Market

2017 (joined 2012)

Head of UK Direct, Hiscox; Vodafone (12 years); Andersen Consulting

—

Paul Lawrence

CUO, Hiscox London Market; Active Underwriter, Syndicate 33

Joined 1992; CUO since Apr 2013

Syndicate 144; E W Payne

—

Kathleen Reardon

CEO, Hiscox Re

Jan 2021

CEO Hamilton Re (2014–20); ACE Tempest Re

BSc Mathematics (Drexel); FCAS

“—” = not publicly disclosed.

Board of Directors

NameRoleJoinedBackground

Peter Clarke

Chair

1 Jun 2025 (Chair from 1 Jul 2025)

Ex-Chair Lancashire Insurance Holdings; Chair of Redwheel; NED of Lombard Odier AM, AXA IM, Sainsbury's Bank

Jane Guyett

Senior Independent Director

Sep 2024

15 years at Bank of America Securities (COO EMEA)

Aki Hussain

Group CEO

—

See above

Paul Cooper

Group CFO

—

See above

Beth Boucher

Independent NED

May 2023

Fortium Partners, SiriusPoint, Travelers, Pfizer, Accenture; NED Coforge

Constantinos (Costas) Miranthis

Independent NED

Nov 2017

Ex-President & CEO PartnerRe; FIA

Donna DeMaio

Independent NED

Apr 2022

Ex-Global COO General Insurance and Global Chief Auditor, AIG; CEO MetLife Bank

June Yee Felix

Independent NED

Jan 2025

Ex-Group CEO IG Group; Chase, Citi, Verifone

Lynne Biggar

Independent NED

Jan 2025

Ex-EVP & Global CMO Visa; American Express; Senior Advisor BCG

Michael Goodwin

Independent NED

Nov 2017

Ex-CEO QBE Asia Pacific; FIAA

Thomas Huerlimann

Independent NED

Nov 2017

Ex-CEO Global Corporate, Zurich; Swiss Re

Board & Management Changes

DateChange

Sep 2024

Jane Guyett joins the Board (later SID)

2024

Mary Boyd joins as CEO, Hiscox USA

Jan 2025

Shali Vasudeva joins as Group COTO; June Yee Felix and Lynne Biggar join the Board

1 Jul 2025

Peter Clarke succeeds Colin Keogh as Chair

2026

Shirley Girling joins as Group General Counsel

Jul 2026

Aparna Sarin joins in the new role of Group Chief Marketing & Revenue Officer

Major Shareholders

HolderStakeDate / source

Société Générale (shares plus CFDs)

5.10% of voting rights (16,422,604)

TR-1, position as of 19 Aug 2026

Other TR-1 filers (Jan, Aug, Sep 2026)

Not identified in sources reviewed

RNS list shows TR-1s on 2, 9 and 15 Jan, 11 and 21 Aug, and 8, 9 and 21 Sep 2026

Remaining top-10 institutional holders

Not publicly disclosed in sources reviewed; see hiscoxgroup.com "Major shareholders"

—

Competitive Landscape

Competitors by Segment

SegmentNamed competitorsPositioning versus Hiscox

Retail – UK SME and professional

Intact Insurance UK (formerly RSA/NIG), Aviva, AXA UK, Allianz UK, Zurich UK, QBE, Markel UK, Travelers (Simply Business distribution)

Hiscox is a specialist brand with strong direct capability. Intact is the UK's third-largest commercial insurer with about 7% share.

Retail – UK high net worth

Chubb, AIG Private Client Select, Ecclesiastical, Zurich Private Clients

Hiscox is a leading HNW specialist with NPS above 80

Retail – Europe

Allianz, AXA, Markel International, Chubb, CNA Hardy, Beazley/Zurich (cyber)

Hiscox is a niche leader in German professional lines and cyber

Retail – US small commercial / digital

The Hartford, Travelers, Chubb, Next Insurance (now part of ERGO/Munich Re), Markel, Berkshire Hathaway (biBERK), Progressive (commercial)

Hiscox is a top-tier digital-direct small-business brand but sub-scale against Hartford and Travelers

London Market / Lloyd's specialty

Beazley (being acquired by Zurich), Lancashire, Brit, Chaucer, Canopius, Markel, Arch, AXA XL, Chubb, Tokio Marine Kiln

Mid-sized, disciplined Lloyd's leader

Reinsurance / ILS

RenaissanceRe, Arch, Everest, Hannover Re, Munich Re, Swiss Re, Lancashire, Nephila/Markel, Fermat, Securis

Mid-tier reinsurer with a fast-growing ILS franchise ($2.9bn AUM)

Peer Comparison FY2025

MetricHiscoxBeazley

Written premium (USD Mn)

4979.0 (ICWP)

6100.7 (IWP)

Premium growth (%)

5.9-1.0

Profit before tax (USD Mn)

732.71,146.5

Undiscounted combined ratio (%)

87.881.0

Return on equity (%)

17.119.0

Recent Developments

The Q3 2026 trading statement. Hiscox typically issues a nine-month statement in late October or early November.

Any H2 2026 North Atlantic hurricane loss estimates.

The change programme targets productivity through technology rather than declared headcount cuts.

Company Snapshot

3,000

Employees

1901

Founded

Bermuda

Headquarters

SWOT Analysis

Strengths

  • Record, compounding profitability. PBT rose from $625.9m (FY2023) to $685.4m (FY2024) to $732.7m (FY2025), three consecutive records (five-year summary).
  • Decade-best underwriting. The FY2025 undiscounted group COR was 87.8%, the best since 2016.
  • Durable retail compounder. Hiscox reports a 20-year unbroken record of Retail premium growth. H1 2026 growth was +8.2% constant currency (+$174.1m gross).
  • Diversification proven under stress. H1 2026 adjusted operating ROTE was 20.2% despite a $60m Middle East loss and soft big-ticket pricing.
  • Capital strength. BSCR of 233% against a 190–200% operating range. AM Best FSR is "A" with ICR "a+" on the main carriers.
  • Fast-growing fee platform. ILS AUM reached $2.9bn (+93% year-to-date). H1 2026 fee income was $53m, against $21m in H1 2025 (Artemis).

Weaknesses

  • Retail margins are mid-pack. The Retail undiscounted COR of 92.6% (FY2025) sits at the high end versus big-ticket and is only marginally improving (92.9% in FY2024).
  • Earnings quality depends on reserve releases. PYD of $292.7m in FY2025 doubled from $145.5m and was about 40% of PBT.
  • Investment mark-to-market volatility. The H1 2026 net fair value loss of $78.4m drove a 13% reported PBT decline.
  • Falling ROE. ROE declined from 27.6% (FY2023) to 19.8% to 17.1%, partly on Bermuda CIT (a 2.5-point ROTE drag in FY2025).
  • Sub-scale and uneven US retail. US broker grew only 0.7% in FY2025, and US growth was 3.5% at 9M 2025 before accelerating.
  • Board tenure concentration. Three NEDs were appointed in November 2017 and are near the nine-year independence threshold.

Opportunities

  • Retail acceleration to double digits by 2028 within a $317bn addressable market.
  • Change programme upside. $45m was delivered in H1 2026 alone, against a $75m FY2026 target; the full $200m is due by 2028.
  • ILS / Hiscox Capital Partners scaling amid record cat bond demand, giving capital-light earnings.
  • European cyber rollout to all markets (H1 2026), plus new professional niches.
  • Takeover premium. Reported Intact interest (May 2026) and Zurich's acquisition of Beazley set a strategic valuation benchmark.
  • Continued buybacks. Surplus capital supports recurring programmes (FY2026: $300m), shrinking the share count by about 5% from end-2024 to mid-2026.

Threats

  • Big-ticket softening. London Market rates -5% and Re -16% in H1 2026; 1 Jan 2026 reinsurance renewals -13%.
  • Catastrophe volatility. LA wildfires cost $170m (2025). Exposure is weighted to the second half (North Atlantic hurricane season).
  • Geopolitical specialty losses. The Middle East conflict cost $60m in H1 2026 across war, terrorism, political violence, marine war and K&R.
  • Competition in US digital small commercial from carriers backed by large reinsurers (e.g., ERGO/Next).
  • Tax and regulatory change. Bermuda CIT is now in force; any further global minimum tax changes would add pressure.
  • Takeover uncertainty. A bid could distract management or crystallise value below intrinsic levels. The absence of a bid may unwind the speculative premium in the shares.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 May 2025Q1 2025 trading statement. ICWP +2.4% to $1,558.0m; Retail +6.1% constant currency; London Market returns to growth (+4.0%).Confirms Retail acceleration
22 May 2025Capital Markets Day: double-digit Retail growth by 2028, $200m programme, BSCR range, 20% dividend step-up. Shares +4.2% to 1,244p.Strategic reset; re-rating catalyst
1 Jun 2025Peter Clarke joins the BoardChair succession
1 Jul 2025Peter Clarke becomes Chair, succeeding Colin KeoghGovernance
31 Jul 2025DirectAsia Singapore sale to Auto & General completesPortfolio simplification
6 Aug 2025H1 2025 results. PBT $276.6m; Re & ILS PBT down to $54m on LA wildfires; COR 92.6%; buyback lifted.Shows diversification absorbing a cat hit
Aug 2025ILS AUM $1.4bn at 30 Jun 2025 after $300m of new inflowsThird-party capital recovering
14 Oct 2025RBC upgrades Hiscox (Sharecast)Sell-side sentiment
Nov 2025Q3 2025 trading statement. 9M ICWP +5.9% to $4,052.9m; Retail +6.1% constant currency; guidance >6% reaffirmed.On track
1 Jan 2026Hiscox Re renewals: rates -13%; ILS AUM $1.5bnReinsurance softening
Jan 2026Several TR-1 major-holding notifications (2, 9 and 15 Jan)Shareholder register movement
Jan 2026Zurich discloses approach for peer Beazley (rejected at 1,230p)Sector M&A context
25 Feb 2026FY2025 results: record PBT $732.7m; 87.8% COR; final DPS +20%; $300m buyback. Shares +5.3% post-results (TipRanks).Third straight record year
26 Feb 2026RBC raises target priceSentiment
2 Mar 2026Zurich agrees to acquire Beazley at 1,335p (c.£8.1bn)Removes main UK listed peer; scarcity value for Hiscox
16 Mar 20262025 Annual Report and 2026 AGM notice publishedFiling
Mar–Oct 2026Weekly "Transaction in own shares" RNS under $300m buybackSteady capital return
1 Apr 2026ILS AUM reaches record $2.4bnHiscox Capital Partners momentum
7 May 2026Q1 2026 trading statement. ICWP +10.2% to $1,717.1m; Retail +8.0% constant currency; Re +7.1%; outlook "positive".Growth step-up
14 May 2026AGM: all 24 resolutions passed, including the Hiscox Share Award PlanGovernance
15 May 2026Insurance Post reports Intact exploring a bid; shares up as much as 15.3% intraday to record highsPotential change of control (unconfirmed)
Jun 2026Middle East conflict losses emergeSpecialty loss event
Jul 2026Aparna Sarin appointed Group CMRO; Insurance Times reports further Intact speculationLeadership; M&A
1 Jul 2026ILS AUM $2.9bn (+93% year-to-date)Fee-income engine
5 Aug 2026H1 2026 results. ICWP +10.1%; adjusted operating PBT +26.3%; reported PBT -13%; Retail guidance raised to 9%; $60m Middle East loss reserved; interim DPS +16.7%. Shares +1.4% to 1,802p.Upgrade cycle
6–10 Aug 2026Analyst updates: targets of 2,150p (Buy), 1,846p (Hold), 1,900p (Buy) (investing.com)Sentiment mixed-positive
17 Aug 2026Buyback programme update RNSCapital return
19–20 Aug 2026Société Générale crosses 5% (5.10%, including CFDs)Event-driven positioning
4 Sep 2026Barclays raises target to 2,030p (from 1,820p), OverweightSentiment
21 Sep 2026Interim dividend (16.8¢) paidCapital return
Sep 2026Further TR-1 notifications (8, 9 and 21 Sep)Register movement
28 Sep 2026Shares at 1,871p, about 4.9% below the 52-week highTrading
5–19 Oct 2026Weekly buybacks of about 337,000–341,000 shares per week; VWAP around 1,851–1,886pOngoing

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Insurance revenue rose from USD 4,273.3 Mn in FY2022 to USD 4,883.7 Mn in FY2025.
Hiscox Ltd — Income Statement: Revenue & Gross Profit
Series (USD Mn)FY2022FY2023FY2024FY2025
Insurance revenue4,273.34,483.24,672.54,883.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Hiscox Group — FY2025 Preliminary Results press release (25 Feb 2026) (hiscoxgroup.com)
  2. Hiscox Group — 2026 Interim Results press release (5 Aug 2026) (hiscoxgroup.com)
  3. Hiscox Group — Five-year summary (hiscoxgroup.com)
  4. Hiscox Group — Management page (hiscoxgroup.com)
  5. Hiscox Group — Q3 2025 trading statement (hiscoxgroup.com)
  6. Hiscox Group — Q1 2025 trading statement (hiscoxgroup.com)
  7. FCA NSM — Capital Markets Day RNS (22 May 2025) (data.fca.org.uk)
  8. Investegate — FY2025 results RNS (investegate.co.uk)
  9. Investegate — H1 2026 interim results RNS (investegate.co.uk)
  10. LSE.co.uk — Q1 2026 trading statement (lse.co.uk)
  11. LSE.co.uk — Total voting rights (1 Apr, 1 Jun, 1 Jul 2026) and AGM results (14 May 2026)
  12. London Stock Exchange — HSX company page (londonstockexchange.com)
  13. Reinsurance News — Hiscox Re FY2025 and H1 2026 coverage (reinsurancene.ws)
  14. Artemis — Hiscox ILS AUM $2.9bn (artemis.bm)
  15. Insurance Business — FY2025 combined ratio; H1 2026 growth; Intact deal talk (insurancebusinessmag.com)
  16. Insurance Times — Briefing: Should Intact make a move for Hiscox? (30 Jul 2026)
  17. Global Banking & Finance / Reuters — Shares jump on Intact report (15 May 2026)
  18. AJ Bell / Alliance News — CMD (May 2025), FY2024, H1 2026 coverage
  19. Insurtech Insights — Hiscox Re FY2025; Q1 2026
  20. Kalkine — Société Générale 5% threshold; October 2026 buybacks
  21. ad-hoc-news.de — Share price, buyback and Barclays target updates (Sep–Oct 2026)
  22. InsuranceNewsNet — AM Best affirmation of Hiscox ratings
  23. DirectAsia press release — Auto & General acquisition (31 Jul 2025)
  24. Insurance Business — Beazley FY2025 results and Zurich acquisition (Mar 2026)
  25. Hampden / Argenta — Syndicate 33 commentary on FY2025 and H1 2026

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.